Centogene NV (Centogene NV) EV-to-Revenue : 2.63 (As of May. 04, 2024)

View and export this data going back to 2019. Start your Free Trial

What is Centogene NV EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Centogene NV's enterprise value is $61.13 Mil. Centogene NV's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was $23.21 Mil. Therefore, Centogene NV's EV-to-Revenue for today is 2.63.

The historical rank and industry rank for Centogene NV's EV-to-Revenue or its related term are showing as below:

CNTG' s EV-to-Revenue Range Over the Past 10 Years
Min: -2.17 Med: -0.49 Max: 9.24
Current: 2.63

During the past 7 years, the highest EV-to-Revenue of Centogene NV was 9.24. The lowest was -2.17. And the median was -0.49.

CNTG's EV-to-Revenue is ranked better than
56.44% of 225 companies
in the Medical Diagnostics & Research industry
Industry Median: 3.04 vs CNTG: 2.63

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-04), Centogene NV's stock price is $0.44285. Centogene NV's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was $0.93. Therefore, Centogene NV's PS Ratio for today is 0.48.

Centogene NV EV-to-Revenue Historical Data

The historical data trend for Centogene NV's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Centogene NV EV-to-Revenue Chart

Centogene NV Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

EV-to-Revenue

Get a 7-Day Free Trial

3.46

4.60

2.69

1.10

Centogene NV Quarterly Data
	Dec17	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Dec22	Jun23
EV-to-Revenue	Get a 7-Day Free Trial															2.69	-1.98	-1.22	1.10	-

Competitive Comparison of Centogene NV's EV-to-Revenue

For the Diagnostics & Research subindustry, Centogene NV's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Centogene NV's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Centogene NV's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Centogene NV's EV-to-Revenue falls into.

Centogene NV EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Centogene NV's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	61.128	/	23.21
	=	2.63

Centogene NV's current Enterprise Value is $61.13 Mil.
Centogene NV's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $23.21 Mil.

Centogene NV (NAS:CNTG) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Centogene NV's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	0.44285	/	0.926
	=	0.48

Centogene NV's share price for today is $0.44285.
Centogene NV's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.93.

Centogene NV EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Centogene NV's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Centogene NV (Centogene NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Centogene NV (NAS:CNTG) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

39K:Germany

Address

Am Strande 7, Rostock, MV, DEU, 18055

Website

https://www.centogene.com

Centogene NV is a United States-based company focused on transforming clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. The company operates in three segments: pharmaceutical, diagnostics, and COVID-19. Its pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. Its clinical diagnostics segment provides targeted genetic sequencing and diagnostics services to patients.